ChromaDex Corporation Reports 2020 Financial Results

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #Earnings--ChromaDex Corp. (NASDAQ:CDXC) today reported fourth quarter and full year 2020 financial results. Fourth Quarter 2020 and Recent Highlights Total net sales of $15.4 million, up 18% from $13.1 million in the year ago quarter. Tru Niagen® net sales of $12.3 million, a 21% increase from the year ago quarter. Gross margin of 61.0%, a 400 basis point increase from the year ago quarter. Net loss was ($6.1) million or ($0.10) per share, an improvement of $0.05 per share y

Click to view original post